Cochlear has announced CE mark approval for Nucleus 6, its next generation cochlear implant sound processor, and that it will now be available throughout Europe.

The Nucleus 6 processor is built on a completely new microchip platform with five times the processing Cochlear nucleus6power of the company’s Nucleus® 5 sound processor.

Nucleus 6 features include:

  • SmartSound iQ advanced sound processing for optimizing performance in hearing situations
  • True automation with a scene classifier, which analyzes the sound environment and automatically applies the best sound processing technology
  • Direct wireless connectivity to the sound processor, linking customers to a wide range of Bluetooth and audio devices
  • Fully integrated hearing aid functionality in every sound processor to boost residual hearing through acoustic stimulation
  • Comprehensive data logging capability, providing information for the clinician to help optimize individual performance
  • The smallest sound processor on the market, according to Cochlear

Cochlear received Canadian approval of the Nucleus 6 in June 2013, and is still awaiting FDA approval for the United States market.

To help launch Nucleus 6, Cochlear created a video called “Molly’s Day” to show its benefits. See the video below or at www.cochlear.com/mollysda

 

 

SOURCE: Cochlear Ltd